Serum Prostatic Specific Antigen Changes After Bipolar and Monopolar TURP

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

2 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-01

Study Completion Date

2023-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To use PSA levels after bipolar and monopolar transurethral resection of the benign prostatic hyperplasia as an indicator of the quality of resection .

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Transurethral Resection Versus Transurethral Enucleation of the Prostate: Prospective Randomized Study

NCT05330156

BPH

UNKNOWN NA

Outcomes and Efficacy of Ejaculatory Preserving Transurethral Resection of Prostate

NCT05914519

Ejaculatory Dysfunction BPH

COMPLETED NA

Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP)

NCT00199550

BPH Benign Prostatic Hyperplasia

COMPLETED PHASE4

To Compare Outcomes After Transurethral Enucleation of Prostate Versus Transurethral Resection of Prostate

NCT01958892

Benign Prostatic Hyperplasia

COMPLETED

Bipolar Resection vs Enucleation of Prostate

NCT06983444

Benign Prostatic Hyperplasia (BPH) Requiring Surgical Resection Benign Prostatic Hyperplasia With Outflow Obstruction Benign Prostatic Hyperplasia With Symptomatic Lower Urinary Tract Symptoms +1 more

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PSA is a protein produced from the prostate epithelium and secreted in semen in huge amounts , small amount find its way to the circulation ,its function is to allow mobility of the sperms by interacting with the Semenogelin . clinical BPH can be defined as prostate adenoma/adenomata, causing a varying degree of BOO, which may eventually cause harm to the patients ,Treatment of this condition varies from conservative, medical and surgical depending on factors related to the patient and the surgeon preference . The early reports of minimally invasive treatment of the prostate dated back to 1937, since then and remarkable development is noticed . TURP is the golden treatment in the BPH . Studies compare between the methods according the blood transfusion , operation time retention after catheter removal , urethral complications , TUR syndrome and hospital-stay which show that bipolar is better. To our knowledge after few studies compare between the techniques according PSA also these studies show weakness in their statistically analysis with no difference between the methods .investigators aim is to study the effect of the operations on PSA levels as an indicator of the quality of resection.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

PSA Changes After TURP

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bipolar TURP

Patients thats will undergo bipolar TURP

Group Type ACTIVE_COMPARATOR

TURP

Intervention Type PROCEDURE

Bipolar and monopolar transurethral resection of the benign prostatic hyperplasia

Monopolar TURP

Patients thats will undergo monopolar TURP

Group Type ACTIVE_COMPARATOR

TURP

Intervention Type PROCEDURE

Bipolar and monopolar transurethral resection of the benign prostatic hyperplasia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TURP

Bipolar and monopolar transurethral resection of the benign prostatic hyperplasia

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients agreeing to participate, clinically fit, age from 50 to 80 years with LUTS related to benign prostate enlargement with no neurological disorder